Manufacturer copay assistance · Zolgensma (J3399) · Novartis Gene Therapies
$0/dose · Maximum benefit Up to $20,000 combined annual limit (CopayAssist Program plus Plus Card and Rebate) · Covers Zolgensma drug cost only — deductibles, copay, and coinsurance
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Zolgensma — the program's cap applies against the patient share CareCost calculates.
Yes — Novartis Zolgensma CopayAssist Program from Novartis Gene Therapies. Eligible patients may pay $0 out of pocket for Zolgensma drug cost. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay $0 out of pocket for Zolgensma drug cost Maximum benefit: Up to $20,000 combined annual limit (CopayAssist Program plus Plus Card and Rebate). Covers Zolgensma drug cost only — deductibles, copay, and coinsurance
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.